The complexes [{Cu(HL)X2·nH2O (HL = 2-formylpyridine thiosemicarbazone, X = CF3CO2, F or I, n= 0; X = Br, n= 2) and [Cu(HL)(H2O)X2]·nH2O (X = ClO4, n= 2; X = NO3, n= 0) have been prepared from the reaction of [{CuL(MeCO2)}2] with the appropriate acid, HX. Also prepared were the deprotonated ligand complexes [(CuLX)2]·nH2O from the reaction of NaL with the appropriate copper(II) salt (X = F, n= 5.5; X =½SO4, n= 3) or by the reaction of [{CuL(MeCO2)}2] with the appropriate sodium salt, NaX (X = N3, n= 1; X = CN, n= 2). The complexes have been characterized by a variety of physicochemical techniques and the crystal and molecular structures of [{Cu(HL)(CF3CO2)}2][CF3CO2]2 and [Cu(HL)(H2O)(ClO4)2]·2H2O determined by single-crystal X-ray diffraction studies. Crystals of [{Cu(HL)(CF3CO2)}2][CF3CO2]2 are triclinic, space group P, with a= 9.6015(7), b= 10.837(1), c= 8.811(2)Å, α= 100.71(1), β= 117.06(1), γ= 80.877(7)°, and Z= 1. The complex cation is a centrosymmetric dimer, the monomeric units being bridged by two CF3CO2– anions. The copper atoms have a distorted square-pyramidal co-ordination geometry with three donor atoms (NNS) coming from HL and the fourth donor (an oxygen) from the bridging anion. The fifth position is occupied by a less strongly bound oxygen from the second bridging anion. Crystals of [Cu(HL)(H2O)(ClO4)2]·2H2O are monoclinic, space group P21/c, with a= 12.9615(5), b= 9.7638(4), c= 14.9964(8)Å, β= 111.580(4)°, and Z= 4. The complex is monomeric with a distorted tetragonal co-ordination around the copper atom. The four in-plane donor atoms are provided by HL (NNS) and an oxygen from a co-ordinated water molecule. Two weakly bound ClO4– ions occupy the fifth and sixth positions. In both complexes hydrogen-bonding schemes appear to be important in stabilizing them in the solid state. The differences in the bonding parameters for the Cu(HL)2+ and CuL+ systems are discussed and related to the fact that the S→CuII ligand-to-metal charge-transfer absorption (at ca. 400 nm) is always observed at higher energies for the HL complexes.
No takes yet. Share an insight, caveat, or question.
Ainscough et al. (1991) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: